|
Comparative adverse cardiac effects of pimobendan and benazepril monotherapy in dogs with mild degenerative mitral valve disease: a prospective, controlled, blinded, and randomized study. ¡¡¡¡¢ª ttp://www.ncbi.nlm.nih.gov/pubmed/17708394
ÁÎ˹ÊÛÊĺ¿ÉÔÁ´¾É¥â¥Ç¥ë¸¤¤ËÂФ¹¤ë¥Ô¥â¥Ù¥ó¥À¥ó¤Î¸ú²Ì(Æâ²Ê³Ø) ¡¡¡¡¢ª ttp://ci.nii.ac.jp/naid/110006250077/
Effects of pimobendan for mitral valve regurgitation in dogs. ¡¡¡¡¢ª ttp://www.ncbi.nlm.nih.gov/pubmed/17485924
Clinical efficacy of pimobendan versus benazepril for the treatment of acquired atrioventricular valvular disease in dogs. ¡¡¡¡¢ª ttp://www.ncbi.nlm.nih.gov/pubmed/16822763
Efficacy and safety of pimobendan in canine heart failure caused by myxomatous mitral valve disease. ¡¡¡¡¢ª ttp://www.ncbi.nlm.nih.gov/pubmed/15789807
Increased mitral valve regurgitation and myocardial hypertrophy in two dogs with long-term pimobendan therapy. ¡¡¡¡¢ª ttp://www.ncbi.nlm.nih.gov/pubmed/15738584
|
Posted by rice | 09:00:00, Mar 21, 2008 | TrackBack:x | Comments:x |